Telomir Pharmaceuticals, Inc. Common Stock
NASDAQ:TELOBiotechnology
Healthcare
$0.69 -3.42%
-$0.04 today
- Market cap
- $50.84M
- Beta
- -0.24
- P/E (TTM)
- -3.8
- EPS (TTM)
- -$0.27
52W Low $0.89High $2.09
Volume 0.17M
Average 0.13M
Price history
Telomir Pharmaceuticals, Inc. Common Stock SEC filings
Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.
Price history
Dividend-adjusted closing price
Period change
-50.36%
Period high
$1.49
Period low
$0.69
Latest
$0.69
SEC filings
What has the company disclosed?
Browse annual, quarterly, and current reports and other filings by form type.
SEC Filings
Recent regulatory filings
| Form | Filing Date | Accepted | |
|---|---|---|---|
| S-3 | Oct 27, 2026 | Oct 27, 2026 | |
| 8-K | Oct 6, 2026 | Oct 6, 2026 | |
| 8-K | Sep 17, 2026 | Sep 17, 2026 | |
| 8-K | Sep 16, 2026 | Sep 16, 2026 | |
| 8-K | Sep 14, 2026 | Sep 14, 2026 | |
| DEFA14A | Aug 19, 2026 | Aug 19, 2026 | |
| SC 13G/A | Aug 14, 2026 | Aug 14, 2026 | |
| 10-Q | Aug 13, 2026 | Aug 13, 2026 | |
| 8-K | Aug 10, 2026 | Aug 10, 2026 | |
| DEF 14A | Jul 28, 2026 | Jul 28, 2026 | |
| 4 | Jul 27, 2026 | Jul 27, 2026 | |
| 4 | Jul 27, 2026 | Jul 27, 2026 | |
| 4 | Jul 27, 2026 | Jul 27, 2026 | |
| 8-K | Jun 15, 2026 | Jun 15, 2026 | |
| 3 | Jun 9, 2026 | Jun 9, 2026 |
Competitors
Who does Telomir Pharmaceuticals, Inc. Common Stock compete with?
Open similar companies to compare their filings and price history.
Competitors
Peer companies in the same sector
Questions
Filing questions
Common questions about TELO's filings, answered from its disclosures.
What is the latest TELO filing?
The latest filing shown is S-3 dated Oct 27, 2026.
How many recent filings does TELO have?
Intrinsic Alpha currently shows 20 recent filings for TELO.
Continue the stock analysis
Jump to another research area for this company.